Literature DB >> 16696854

Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non-neuronal cells.

Catherine Grenier1, Cyntia Bissonnette, Leonid Volkov, Xavier Roucou.   

Abstract

Recent studies have revealed that accumulation of prion protein (PrP) in the cytoplasm results in the production of aggregates that are insoluble in non-ionic detergents and partially resistant to proteinase K. Transgenic mice expressing PrP in the cytoplasm develop severe ataxia with cerebellar degeneration and gliosis, suggesting that cytoplasmic PrP may play a role in the pathogenesis of prion diseases. The mechanism of cytoplasmic PrP neurotoxicity is not known. In this report, we determined the molecular morphology of cytoplasmic PrP aggregates by immunofluorescence and electron microscopy, in neuronal and non-neuronal cells. Transient expression of cytoplasmic PrP produced juxtanuclear aggregates reminiscent of aggresomes in human embryonic kidney 293 cells, human neuroblastoma BE2-M17 cells and mouse neuroblastoma N2a cells. Time course studies revealed that discrete aggregates form first throughout the cytoplasm, and then coalesce to form an aggresome. Aggresomes containing cytoplasmic PrP were 1-5-microm inclusion bodies and were filled with electron-dense particles. Cytoplasmic PrP aggregates induced mitochondrial clustering, reorganization of intermediate filaments, prevented the secretion of wild-type PrP molecules and diverted these molecules to the cytoplasm. Cytoplasmic PrP decreased the viability of neuronal and non-neuronal cells. We conclude that any event leading to accumulation of PrP in the cytoplasm is likely to result in cell death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16696854      PMCID: PMC2954960          DOI: 10.1111/j.1471-4159.2006.03837.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

Review 1.  Hassles with taking out the garbage: aggravating aggresomes.

Authors:  Rafael Garcia-Mata; Ya-Sheng Gao; Elizabeth Sztul
Journal:  Traffic       Date:  2002-06       Impact factor: 6.215

2.  Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.

Authors:  Jiyan Ma; Susan Lindquist
Journal:  Science       Date:  2002-10-17       Impact factor: 47.728

3.  The effects of aggregation-inducing motifs on amyloid formation of model proteins related to neurodegenerative diseases.

Authors:  Motomasa Tanaka; Yoko Machida; Yukihiro Nishikawa; Takumi Akagi; Isao Morishima; Tsutomu Hashikawa; Tetsuro Fujisawa; Nobuyuki Nukina
Journal:  Biochemistry       Date:  2002-08-13       Impact factor: 3.162

4.  Cytosolic prion protein in neurons.

Authors:  Alexander Mironov; Diane Latawiec; Holger Wille; Essia Bouzamondo-Bernstein; Giuseppe Legname; R Anthony Williamson; Dennis Burton; Stephen J DeArmond; Stanley B Prusiner; Peter J Peters
Journal:  J Neurosci       Date:  2003-08-06       Impact factor: 6.167

5.  Mutant prion protein-mediated aggregation of normal prion protein in the endoplasmic reticulum: implications for prion propagation and neurotoxicity.

Authors:  Yaping Gu; Susamma Verghese; Ravi Shankar Mishra; Xeumin Xu; Yongchang Shi; Neena Singh
Journal:  J Neurochem       Date:  2003-01       Impact factor: 5.372

6.  Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.

Authors:  Jiyan Ma; Robert Wollmann; Susan Lindquist
Journal:  Science       Date:  2002-10-17       Impact factor: 47.728

7.  Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.

Authors:  Ravi Shankar Mishra; Sharmila Bose; Yaping Gu; Ruliang Li; Neena Singh
Journal:  J Alzheimers Dis       Date:  2003-02       Impact factor: 4.472

8.  Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells.

Authors:  Ehud Cohen; Albert Taraboulos
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

9.  Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration.

Authors:  Laure Debure; Jean-Luc Vayssiere; Vincent Rincheval; Fabien Loison; Yves Le Drean; Denis Michel
Journal:  J Cell Sci       Date:  2003-06-10       Impact factor: 5.285

10.  Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation.

Authors:  Bettina Drisaldi; Richard S Stewart; Cheryl Adles; Leanne R Stewart; Elena Quaglio; Emiliano Biasini; Luana Fioriti; Roberto Chiesa; David A Harris
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

View more
  25 in total

1.  Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.

Authors:  Sandrine Alais; Ricardo Soto-Rifo; Vincent Balter; Henri Gruffat; Evelyne Manet; Laurent Schaeffer; Jean Luc Darlix; Andrea Cimarelli; Graça Raposo; Théophile Ohlmann; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway.

Authors:  Sang-Wook Kang; Neena S Rane; Soo Jung Kim; Jennifer L Garrison; Jack Taunton; Ramanujan S Hegde
Journal:  Cell       Date:  2006-12-01       Impact factor: 41.582

3.  Dynamic interactions of Sup35p and PrP prion protein domains modulate aggregate nucleation and seeding.

Authors:  Carmen Krammer; Elisabeth Kremmer; Hermann M Schätzl; Ina Vorberg
Journal:  Prion       Date:  2008 Jul-Sep       Impact factor: 3.931

4.  Abnormal calcium homeostasis and protein folding stress at the ER: A common factor in familial and infectious prion disorders.

Authors:  Mauricio Torres; Gonzalo Encina; Claudi Soto; Claudio Hetz
Journal:  Commun Integr Biol       Date:  2011-05

5.  Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity.

Authors:  Christopher F Harrison; Victoria A Lawson; Bradley M Coleman; Yong-Sun Kim; Colin L Masters; Roberto Cappai; Kevin J Barnham; Andrew F Hill
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

6.  Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion.

Authors:  Sarah Refaie; Sandra Gagnon; Hugo Gagnon; Roxane Desjardins; François D'Anjou; Pedro D'Orléans-Juste; Xiaorong Zhu; Donald F Steiner; Nabil G Seidah; Claude Lazure; Michel Salzet; Robert Day
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

7.  Spautin-1 Ameliorates Acute Pancreatitis via Inhibiting Impaired Autophagy and Alleviating Calcium Overload.

Authors:  Juan Xiao; Xueping Feng; Xiao-Ying Huang; Zhongshi Huang; Yanqiang Huang; Chaogan Li; Genliang Li; Song Nong; Ruoshi Wu; Yongzhi Huang; Xi-Dai Long
Journal:  Mol Med       Date:  2016-08-18       Impact factor: 6.354

8.  Cell type-specific neuroprotective activity of untranslocated prion protein.

Authors:  Elena Restelli; Luana Fioriti; Susanna Mantovani; Simona Airaghi; Gianluigi Forloni; Roberto Chiesa
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

9.  Cytoplasmic prion protein induces forebrain neurotoxicity.

Authors:  Xinhe Wang; Stephanie L Bowers; Fei Wang; Xin-An Pu; Randy J Nelson; Jiyan Ma
Journal:  Biochim Biophys Acta       Date:  2009-03-10

10.  Observing fibrillar assemblies on scrapie-infected cells.

Authors:  Susanne Wegmann; Margit Miesbauer; Konstanze F Winklhofer; Jörg Tatzelt; Daniel J Muller
Journal:  Pflugers Arch       Date:  2008-01-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.